TY  - JOUR
AU  - Rodriguez-Pallares, Jannette
AU  - Rodriguez-Perez, Ana I
AU  - Muñoz, Ana
AU  - Parga, Juan A
AU  - Toledo-Aral, Juan J
AU  - Labandeira-Garcia, Jose L
PY  - 2016
DO  - 10.5966/sctm.2015-0182
SN  - 2157-6564
UR  - http://hdl.handle.net/10668/9995
T2  - Stem cells translational medicine
AB  - In models of Parkinson's disease (PD), Rho kinase (ROCK) inhibitors have antiapoptotic and axon-stabilizing effects on damaged neurons, decrease the neuroinflammatory response, and protect against dopaminergic neuron death and axonal retraction. ROCK...
LA  - en
KW  - Cell therapy
KW  - Dopamine
KW  - Neuroprotection
KW  - Parkinson
KW  - Rho kinase
KW  - Striatum
KW  - Transplantation
KW  - Animals
KW  - Apoptosis
KW  - Cell- and Tissue-Based Therapy
KW  - Corpus Striatum
KW  - Disease Models, Animal
KW  - Dopamine
KW  - Dopaminergic Neurons
KW  - Enzyme Inhibitors
KW  - Humans
KW  - Mesencephalon
KW  - Neuroprotective Agents
KW  - Parkinson Disease
KW  - Rats
KW  - Transplants
KW  - rho-Associated Kinases
TI  - Effects of Rho Kinase Inhibitors on Grafts of Dopaminergic Cell Precursors in a Rat Model of Parkinson's Disease.
TY  - research article
VL  - 5
ER  -